Industries / Health / Healthcare / Hospice
Comfort care
Relieving pain, breathlessness, agitation and other distressing symptoms in the last weeks and days of life, with drugs, devices and plans for care.
7
Milestones achieved, from 1977 to 2017.
2
To watch for: announced, not yet confirmed outside.
2
Open deliverables. Nobody has shipped them.
The road
AchievedWatch forOpen
Achieved
1977
Morphine matches heroin by mouth
R. G. Twycross ran a controlled trial in 699 people with terminal cancer of diamorphine (heroin) against morphine, both given regularly by mouth in doses set for each person; 146 crossed from one drug to the other after about two weeks. He concluded that morphine is a satisfactory substitute for diamorphine by mouth once the difference in strength, about 1.5 to 1, is allowed for. Diamorphine kept one practical advantage: it dissolves far more readily, which matters when large doses must be injected.
Credit
R. G. Twycross (Pain, 1977)
1979
Medicine by slow pump
B. M. Wright and K. Callan described slow drug infusions with a portable syringe driver, a small pump that pushes a syringe plunger at a set speed, in the BMJ in 1979. Built first for children with thalassaemia, a blood disorder treated by slow infusions, it was taken up in British palliative care from the early 1980s to give medicines continuously under the skin. A 2018 government review says these pumps let patients stay at home and kept pain managed overnight.
pmc.ncbi.nlm.nih.govebi.ac.ukassets.publishing.service.gov.uk
Credit
B. M. Wright; history by Fiona Graham and David Clark (Journal of Pain and Symptom Management, 2005)
1986
Three steps for cancer pain
The World Health Organization's Cancer Pain Relief (1986) set out a method in three steps: non-opioid painkillers, then weak opioids, then strong opioids, with other drugs added at any step. In a two-year review at the WHO collaborating centre in Milan's National Cancer Institute, the method worked in 71% of cases and cut pain to about a third of its starting intensity.
LessonThe Milan authors wrote that the real obstacle was a lack of opioids, or their underuse, not the method.
Credit
WHO expert group; V. Ventafridda and colleagues (Cancer, 1987)
1993
Morphine reaches Uganda
Anne Merriman founded Hospice Africa Uganda in Kampala in September 1993, with funds for three clinicians for three months. Uganda then changed its law so that nurses and clinical officers with special palliative care training could prescribe morphine; Merriman writes that these nurse prescribers have brought palliative care to 90% of districts. Since 2011 the hospice has made oral liquid morphine for the whole country under licence from the Ministry of Health, and the government gives it free to patients with a prescription.
Credit
Anne Merriman and Hospice Africa Uganda; Uganda Ministry of Health
2010
Oxygen no better than air
Oxygen was widely given for breathlessness to people with life-limiting illness whose blood oxygen was not low. A double-blind trial at nine sites in Australia, the US and the UK gave 239 such patients either oxygen or room air through the same nasal tube at 2 litres a minute for seven days. Breathlessness eased by the same amount in both groups.
LessonThe authors advised less burdensome measures than a concentrator worn 15 hours a day.
Credit
A. P. Abernethy and colleagues (Lancet, 2010)
2010
Lookalike pumps withdrawn
The Graseby syringe drivers that dominated the UK market set speed in millimetres of plunger travel, not millilitres: two models ran in millimetres per hour and one in millimetres per 24 hours, so the same setting could mean a rate 24 times different. From January 2005 to June 2010, England's incident database held 175 errors with these pumps, including eight deaths from over-infusion. On 16 December 2010 the National Patient Safety Agency told providers to replace them within five years with pumps that have extra safety features.
LessonTwo pumps that look alike must not count time differently.
Credit
National Patient Safety Agency; review by the Department of Health and Social Care (2018)
2017
Antipsychotics worsen delirium
Delirium is sudden confusion, common near the end of life, and antipsychotic drugs were widely used for it without trials against a placebo. In a double-blind trial in 11 Australian hospice and hospital palliative care services, 247 patients got risperidone, haloperidol or a placebo by mouth for three days. Symptoms were worse on both drugs than on placebo, side effects such as stiffness and tremor were more common, and survival was shorter on haloperidol.
LessonTreating the causes of delirium, with supportive care, did better without the drugs.
Credit
M. R. Agar and colleagues (JAMA Internal Medicine, 2017)
Watch for
Lorazepam calms agitated delirium
At three acute palliative care units in Taiwan and the US, 75 people with advanced cancer whose agitation persisted despite standard haloperidol were given blinded haloperidol, lorazepam, both, or a placebo every four hours. The two lorazepam groups were calmer within 24 hours and needed fewer rescue doses, with no difference in side effects or survival.
Achieved whena second trial in another group of patients repeats the result, or a national guideline adopts scheduled lorazepam on this evidence.
Claimed by
D. Hui and colleagues, MD Anderson Cancer Center (JAMA Oncology), July 2025
Virtual reality at the bedside
VA Boston began piloting a virtual reality headset on the hospice unit of its Brockton campus in January 2026. In a VA study of 25 veterans in inpatient hospice and palliative care, 91% said they enjoyed the sessions and 90% would do it again; changes in anxiety and mood came from the veterans' feedback, not from measured outcomes.
Achieved whena controlled trial shows less pain or anxiety than in a comparison group.
Claimed by
VA Boston Healthcare System, January 2026; M. E. Gately and colleagues (Journal of Palliative Medicine), 2026
Open
01
Hand fans on the bench
A public table of the handheld fans sold for breathlessness, the feeling of being short of breath that many people have near the end of life. For each fan, give the airflow at 15 cm and 30 cm from the face at every speed setting, with the noise in decibels, the weight and the battery run time. Measure on the bench only, with no patients.
The briefCredit · unclaimed02
Syringe drivers on the bench
An independent bench test of the ambulatory syringe drivers used in palliative care, such as BD's BodyGuard T and the CME T34 models still in service, run with water into a lab balance for 24 hours at the low rates used under the skin. Publish delivered against programmed volume, start-up delay and the size of any bolus, an unintended surge, for each model and syringe brand.
The briefCredit · unclaimed
Open 01 · the brief
Hand fans on the bench
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
A public table of the handheld fans sold for breathlessness, the feeling of being short of breath that many people have near the end of life. For each fan, give the airflow at 15 cm and 30 cm from the face at every speed setting, with the noise in decibels, the weight and the battery run time. Measure on the bench only, with no patients.
Why it is still open
In a 2023 study at the University of Hull with healthy volunteers, recovery from breathlessness after exercise was faster only at airflow speeds of 1.7 m/s or more, yet the enclosed-blade fan that most participants preferred reached just 1.0 m/s. The authors concluded that "alternative fan designs are required". The only published measurement of fans on sale that they cite is Smith and colleagues' 2022 test of five fans with 33 people with lung disease, and searches found no wider public comparison.
Built with what exists
an airflow meter, such as the Testo 405i probe the Hull team used; a duct and a fixed stand made on a 3D printer; a sound level meter; a microcontroller that logs battery run time; Python to publish the table.
First step
Buy the two fan types the Hull team used, rebuild their duct test and check that the readings come within 10% of the 0.7 to 3.3 m/s they published.
Done looks like
At least 30 fans bought at retail in at least three countries, each measured three times at each setting, with the repeat readings within 10% of each other. The table marks which fans reach 1.7 m/s at 15 cm, and the method and raw readings are public.
Open 02 · the brief
Syringe drivers on the bench
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
An independent bench test of the ambulatory syringe drivers used in palliative care, such as BD's BodyGuard T and the CME T34 models still in service, run with water into a lab balance for 24 hours at the low rates used under the skin. Publish delivered against programmed volume, start-up delay and the size of any bolus, an unintended surge, for each model and syringe brand.
Why it is still open
The UK medicines regulator, MHRA, listed four separate faults with T34 drivers in 2021, including a bolus when the pump stands in direct sunlight, and said there are "very few alternative pumps" for the same use. A European metrology project published tests of drug delivery devices at very low flow rates in 2022, but of two other device types, and the only comparisons of these palliative drivers that searches found come from their maker, BD.
Built with what exists
second-hand or loaned drivers; a lab balance reading to 0.1 mg, with a draught shield and an evaporation trap, to weigh the water delivered; syringes of several brands; water only; Python to log the balance every second.
First step
Borrow one driver from a hospital equipment library and run a 24-hour test at 1 mL per hour to check the balance and evaporation set-up.
Done looks like
At least three models, three units each, run three times at three rates for 24 hours. Results are given as percentage error per hour with the raw logs, and the test is repeated by a second lab or university to within 2 percentage points.